Molecule to Market: Inside the outsourcing space

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm. Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene has probably seen more than most in drug development! Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gene, speaking on the transformation of the

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Detlef Behrens, founder at Bay Pharma. A PhD pharmacist by training, Detlef is a seasoned industry professional having spent 20 years in the pharmaceutical and biotechnology space. He’s worked for several global CDMOs and now runs a biotech company. He is one of a rare breed that has seen drug development from both the CRAMS/CDMO/CMO vendor side of the fence and the sponsor

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with  Barbara Morgan, Global Business Director for Pharma and Nutra at Lubrizol. A PhD chemist by trade, Barbara has gone from working at the Broad Institute of MIT and Harvard in 2009, to heading the CDMO and Nutra division of Lubrizol, an incredible trajectory in 10 years. Along the way, she’s headed up teams, worked in the VC/M&A space and held a variety of very interesting roles in

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Stanton, Editor and Founder of BioProcess Insider, an online publication focused on reporting the latest business news and opinion across the biomanufacturing space and part of the BioProcess International brand. Dan is also the Managing Editor at Xconomy and was formerly the Editor of Biopharma-Reporter and In-Pharmatechnologist. Dan has particular expertise in biotech,

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefano Console, a life science specialist with over 25 years of experience in the pharmaceutical and fine chemical sector. Stefano is the Senior Advisor at Oriento, a life sciences consultancy organization specializing in contract development and manufacturing organizations both in active pharmaceutical ingredients and finished dosage forms. Stefano is also a Member of the

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jitesh Devendra, Managing Director at Solara Active Pharma Sciences. As former president of Shasun Formulation Jitesh has 20 years of experience in managing sales and business development both on API's and Formulation. Originally from Chennai, India, Jitesh has traveled the world and gained much experience along his journey. Your host, Raman Sehgal, and guest, Jitesh Devendra

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with JoyL Silva, General Manager at Pfizer CentreOne. JoyL joined Pfizer over 20 years ago and has successfully risen through a series of commercial leadership roles with the company. She serves on the board of Pharma and Biopharma Outsourcing Association (PBOA), was named as a rising star in 2012 by Healthcare Businesswomen's Association and was recently listed in the 2020 Medicine

An introductory episode to your new favorite podcast. Gain invaluable insight and listen in on candid, compelling conversations from today's life science leaders in the outsourcing space.